MAPT and Alzheimer disease: Although affinity sensing based on QCM transduction has been successfully applied to aggregation kinetic studies [15] and AD clinical diagnostics [16,17] based on amyloid-β detection, to our best knowledge its application to tau protein detection has not been reported so far.